# Resveratrol Blood Pressure Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/resveratrol-blood-pressure-randomized-trial-evidence-review
Category: evidence-review
Summary: Resveratrol Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass
Last reviewed: 2026-05-28
Reviewed by: Migaku Evidence Review
# Resveratrol Blood Pressure Randomized Trial: What the Evidence Says

## Quick Answer

Resveratrol Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials | systematic review | 1 | 2026-04-15 | 10.1186/s12937-026-01319-5 |
| Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases | preclinical study | 4 | 2026-02-27 | 10.21873/invivo.14235 |

## What The Sources Report

- Resveratrol is a polyphenol belonging to the family of stilbenes, predominantly found in grapes and wine. [Sun Jia-Nan (2026); evidence level 1]
- Growing clinical trials have indicated its potential to reduce the risk and progression of various chronic diseases, such as type 2 diabetes mellitus (T2DM), cardiovascular disease (CVD), and cognitive disorders. [Sun Jia-Nan (2026); evidence level 1]
- Given the strong association between excess adiposity and the risk of NCDs, interventions capable of modulating obesity-related metabolic disturbances are of clinical interest. [SHEN CHUN-YU (2026); evidence level 4]
- Resveratrol, a naturally occurring polyphenolic stilbene found in grapes, berries, and peanuts, has attracted considerable scientific interest due to its potential cardiometabolic benefits. [SHEN CHUN-YU (2026); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For resveratrol blood pressure randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Sun Jia-Nan (2026). Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials. DOI: 10.1186/s12937-026-01319-5. PMCID: PMC13196030. PMID: 41987155. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC13196030/
- SHEN CHUN-YU (2026). Resveratrol Supplementation and its Potential Benefits in Obesity-related Non-communicable Diseases. DOI: 10.21873/invivo.14235. PMCID: PMC12949888. PMID: 41760304. License: https://creativecommons.org/licenses/by-nc-nd/4.0/. https://pmc.ncbi.nlm.nih.gov/articles/PMC12949888/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.